|Westchester Country Club|
President Trump's physician is treating his coronavirus diagnosis with Regeneron's experimental treatment and his one infusion "seemed to go through very well" and "will last a long time," the company's chief scientific officer explained to the media.
Regeneron confirmed it has released the drug under the "Compassionate Use Request" in which the Food & Drug Administration permits usage to those not in clinical trials, according to the Mayo Clinic. Normally, this process is long and challenging.
"We figured out ways to make the best of the antibodies that your body makes but we can make them outside of the body in these huge bioreactors, purify them and give them back to you in highly-concentrated form so it's like we're substituting for or supplementing your own immune system with these very powerful antibodies," Dr. George Yancopoulos, the co-founder, President and chief scientific officer of Regeneron Pharmaceuticals said.
Media reports Trump has held stock in Regeneron since 2017 and the drug maker execs belong to the same golf club in New York’s Westchester County as the President (fees $18,500 per year).
Click here for the CNN Business report showing the Trump/Regeneron ties.
By the end of the news cycle yesterday, Dr. Yancopoulos announced to the media that he would honor a Compassionate use request made by the Biden campaign if asked.